Grafa makes finance simple and entertaining. It allows anyone, anywhere in the world to quickly research, get tips and understand investment opportunities.
Bristol Myers Squibb
Grafa topics
Grafa
11/11/2024
AbbVie stock plunges after schizophrenia drug trial failure
Grafa
31/10/2024
Bristol Myers Squibb Q3 revenue soars 8%, new drug approved
Grafa
22/10/2024
LBT Innovations lands first US sale of APAS Independence instrument
Grafa
22/10/2024
LBT Innovations erzielt ersten Verkauf des APAS Independence Instruments in den USA.
Grafa
27/09/2024
Bristol Myers Squibb shares surge after FDA approval of new schizophrenia drug
Grafa
26/07/2024
Bristol-Myers Squibb (NYSE:BMY) posts 9% revenue jump in Q2 2024
Grafa
14/02/2024
Bristol Myers Squibb (NYSE:BMY) warns shareholders against low-ball tender offer
Grafa
23/01/2024
Mirati Therapeutics (NASDAQ:MRTX) merges with Bristol-Myers Squibb in $4.8B deal
Hub
News
Watchlist
Hot
Markets